7-16797830-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006408.4(AGR2):​c.331-136G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0675 in 641,504 control chromosomes in the GnomAD database, including 3,358 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1929 hom., cov: 33)
Exomes 𝑓: 0.053 ( 1429 hom. )

Consequence

AGR2
NM_006408.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.52

Publications

3 publications found
Variant links:
Genes affected
AGR2 (HGNC:328): (anterior gradient 2, protein disulphide isomerase family member) This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, a catalytically active thioredoxin domain, and a C-terminal ER-retention sequence. This protein plays a role in cell migration, cellular transformation and metastasis and is as a p53 inhibitor. As an ER-localized molecular chaperone, it plays a role in the folding, trafficking, and assembly of cysteine-rich transmembrane receptors and the cysteine-rich intestinal gylcoprotein mucin. This gene has been implicated in inflammatory bowel disease and cancer progression. [provided by RefSeq, Mar 2017]
AGR2 Gene-Disease associations (from GenCC):
  • respiratory infections, recurrent, and failure to thrive with or without diarrhea
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.281 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGR2NM_006408.4 linkc.331-136G>A intron_variant Intron 5 of 7 ENST00000419304.7 NP_006399.1 O95994Q4JM46
AGR2XM_005249581.5 linkc.331-136G>A intron_variant Intron 5 of 7 XP_005249638.1 O95994Q4JM46

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGR2ENST00000419304.7 linkc.331-136G>A intron_variant Intron 5 of 7 1 NM_006408.4 ENSP00000391490.2 O95994

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17202
AN:
151982
Hom.:
1924
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0787
Gnomad ASJ
AF:
0.0672
Gnomad EAS
AF:
0.196
Gnomad SAS
AF:
0.0453
Gnomad FIN
AF:
0.0550
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0285
Gnomad OTH
AF:
0.0881
GnomAD4 exome
AF:
0.0532
AC:
26038
AN:
489404
Hom.:
1429
AF XY:
0.0508
AC XY:
13060
AN XY:
257204
show subpopulations
African (AFR)
AF:
0.288
AC:
3820
AN:
13252
American (AMR)
AF:
0.0817
AC:
1630
AN:
19948
Ashkenazi Jewish (ASJ)
AF:
0.0677
AC:
964
AN:
14242
East Asian (EAS)
AF:
0.169
AC:
5254
AN:
31082
South Asian (SAS)
AF:
0.0411
AC:
1827
AN:
44502
European-Finnish (FIN)
AF:
0.0572
AC:
1971
AN:
34438
Middle Eastern (MID)
AF:
0.0522
AC:
119
AN:
2278
European-Non Finnish (NFE)
AF:
0.0285
AC:
8609
AN:
302578
Other (OTH)
AF:
0.0681
AC:
1844
AN:
27084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1100
2201
3301
4402
5502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.113
AC:
17244
AN:
152100
Hom.:
1929
Cov.:
33
AF XY:
0.113
AC XY:
8433
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.286
AC:
11839
AN:
41466
American (AMR)
AF:
0.0789
AC:
1205
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0672
AC:
233
AN:
3466
East Asian (EAS)
AF:
0.196
AC:
1012
AN:
5170
South Asian (SAS)
AF:
0.0447
AC:
215
AN:
4808
European-Finnish (FIN)
AF:
0.0550
AC:
582
AN:
10582
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0285
AC:
1939
AN:
68012
Other (OTH)
AF:
0.0943
AC:
199
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
697
1394
2091
2788
3485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0634
Hom.:
270
Bravo
AF:
0.125
Asia WGS
AF:
0.134
AC:
465
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.022
DANN
Benign
0.39
PhyloP100
-2.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2280655; hg19: chr7-16837454; API